Literature DB >> 33258001

The influence of prescriber and patient gender on the prescription of benzodiazepines: evidence for stereotypes and biases?

Roger S McIntyre1,2,3,4, Vincent Chin-Hung Chen5,6, Yena Lee1, Leanna M W Lui1, Amna Majeed1, Mehala Subramaniapillai1, Rodrigo B Mansur1, Joshua D Rosenblat1, Yao-Hsu Yang7,8,9, Yi-Lung Chen10,11.   

Abstract

PURPOSE: Benzodiazepines are commonly prescribed globally. We hypothesize that gender stereotypes influence benzodiazepine prescriptions insofar as male prescribers are more likely to prescribe benzodiazepines to female patients.
METHODS: Our nationwide cohort study included 2,127,441 patients with a psychiatric disorder (ICD-9 codes 290-319) and 38,932 prescribers as part of the Taiwan National Health Insurance Research Database (1997-2013). We evaluated the effects of patient and prescriber gender on the proportion of patients prescribed benzodiazepines and the cumulative dosage of benzodiazepine prescription (mg) using generalized estimating equation and general linear models.
RESULTS: The proportion of patients prescribed benzodiazepines was higher among male (vs. female) prescribers [odds ratio (OR) = 1.06, 95% confidence interval (CI) = 1.05-1.07] and among female (vs. male) patients (OR = 1.08, 95% CI = 1.08-1.09). Similarly, male prescriber gender (β = 10,292.2, SE = 1265.5, p < 0.001) and female patient gender (β = 7913.7, SE = 627.1, p < 0.001) predicted higher cumulative dosages of benzodiazepine prescription. Mean cumulative dosage was highest among female patients seen by male prescribers (β = 4283.7, SE = 717.6, p < 0.001). The results were consistent in sensitivity analyses of patients with anxiety disorder (n = 1,632,363), major depression (n = 1,122,796), or chronic administration (n = 1,981,819), and prescribers with psychiatrists (n = 1276), and non-psychiatrists (n = 33,268).
CONCLUSIONS: Male prescribers were more likely to prescribe benzodiazepines to female patients relative to male patients. This gender bias in prescription is significant and warrants careful attention at point of care. We hypothesize that internalized societal biases and stereotypes affect benzodiazepine prescribing behaviour.

Entities:  

Keywords:  Benzodiazepine; Cohort study; Depression; Gender bias; Mental disorders; Population-based database

Year:  2020        PMID: 33258001     DOI: 10.1007/s00127-020-01989-4

Source DB:  PubMed          Journal:  Soc Psychiatry Psychiatr Epidemiol        ISSN: 0933-7954            Impact factor:   4.328


  6 in total

1.  Benzodiazepine use in the United States.

Authors:  Mark Olfson; Marissa King; Michael Schoenbaum
Journal:  JAMA Psychiatry       Date:  2015-02       Impact factor: 21.596

2.  Racial influence on diagnosis in psychotic mania.

Authors:  S M Strakowski; S L McElroy; P E Keck; S A West
Journal:  J Affect Disord       Date:  1996-07-08       Impact factor: 4.839

3.  External incubation alters the composition of squamate eggshells.

Authors:  D L Cox; T J Koob; R P Mecham; O J Sexton
Journal:  Comp Biochem Physiol B       Date:  1984

4.  Gender differences in prescribing of zolpidem in the Veterans Health Administration.

Authors:  Guneet K Jasuja; Joel I Reisman; Renda Soylemez Weiner; Melissa L Christopher; Adam J Rose
Journal:  Am J Manag Care       Date:  2019-03-01       Impact factor: 3.247

5.  Prevalence of use of non-prescription analgesics in the Norwegian HUNT3 population: Impact of gender, age, exercise and prescription of opioids.

Authors:  Ola Dale; Petter C Borchgrevink; Olav Magnus S Fredheim; Milada Mahic; Pål Romundstad; Svetlana Skurtveit
Journal:  BMC Public Health       Date:  2015-05-02       Impact factor: 3.295

6.  Benzodiazepine prescribing for children, adolescents, and young adults from 2006 through 2013: A total population register-linkage study.

Authors:  Anna Sidorchuk; Kayoko Isomura; Yasmina Molero; Clara Hellner; Paul Lichtenstein; Zheng Chang; Johan Franck; Lorena Fernández de la Cruz; David Mataix-Cols
Journal:  PLoS Med       Date:  2018-08-07       Impact factor: 11.069

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.